Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 531-541

  Anselmo, Aaron C ^a   Mitragotri, Samir ^a  

^a Santa Barbara   (United States)

Author keywords

Blood; Cell mediated drug delivery; Cellular hitchhiking; Nanomedicine; Nanoparticles; Nanotechnology

Indexed keywords

BLOOD; CYTOLOGY; DRUG DELIVERY; IMMUNE SYSTEM; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOTECHNOLOGY;

CELLULAR HITCHHIKING; DRUG DELIVERY SYSTEM; FUNCTIONAL ATTRIBUTE; NUTRIENT DELIVERY; POOR CIRCULATIONS; SYNTHETIC NANOPARTICLES; VASCULATURE;

CELLS;

MACROGOL; NANOPARTICLE; DOXORUBICIN; INDINAVIR; LIPOSOME; POLYSTYRENE;

ADSORPTION; ANTIBODY PRODUCTION; CELL ADHESION; CELL DAMAGE; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CELLULAR HITCHHIKING; CIRCULATION TIME; CONTROLLED DRUG RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ERYTHROCYTE; HEART OUTPUT; HUMAN; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; IN VIVO STUDY; INTERNALIZATION; LEUKOCYTE; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TARGET CELL; THROMBOCYTE; VASCULARIZATION; B LYMPHOCYTE; CELLS; CONJUGATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; MEMORY T LYMPHOCYTE; ANIMAL; CHEMISTRY; METABOLISM;

ANIMALS; CELLS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES;

EID: 84906787396     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.03.050     Document Type: Review

References (81)

1. B.A. Myhre The first recorded blood transfusions: 1656 to 1668 Transfusion 30 1990 358 362 (Pubitemid 20180831)
2. H.G. Klein, and D.J. Anstee Mollison's Blood Transfusion in Clinical Medicine: Wiley. com 2008
3. S.A. Rosenberg, J.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat. Med. 10 2004 909 915 (Pubitemid 39273730)
4. A.I. Caplan Adult mesenchymal stem cells for tissue engineering versus regenerative medicine J. Cell. Physiol. 213 2007 341 347 (Pubitemid 47509711)
5. J.W. Yoo, D.J. Irvine, D.E. Discher, and S. Mitragotri Bio-inspired, bioengineered and biomimetic drug delivery carriers Nat. Rev. Drug Discov. 10 2011 521 535
6. I. Mellman, G. Coukos, and G. Dranoff Cancer immunotherapy comes of age Nature 480 2011 480 489
7. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
8. N. Doshi, J.N. Orje, B. Molins, J.W. Smith, S. Mitragotri, and Z.M. Ruggeri Platelet mimetic particles for targeting thrombi in flowing blood Adv. Mater. 24 2012 3864 3869
9. N. Doshi, A.S. Zahr, S. Bhaskar, J. Lahann, and S. Mitragotri Red blood cell-mimicking synthetic biomaterial particles Proc. Natl. Acad. Sci. U. S. A. 106 2009 21495 21499
10. C.-M.J. Hu, L. Zhang, S. Aryal, C. Cheung, R.H. Fang, and L. Zhang Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform Proc. Natl. Acad. Sci. 108 2011 10980 10985
11. A. Parodi, N. Quattrocchi, A.L. van de Ven, C. Chiappini, M. Evangelopoulos, and J.O. Martinez et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions Nat. Nanotechnol. 8 2013 61 68
12. P.L. Rodriguez, T. Harada, D.A. Christian, D.A. Pantano, R.K. Tsai, and D.E. Discher Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles Science 339 2013 971 975
13. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760 (Pubitemid 350223348)
14. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318 (Pubitemid 32476118)
15. D.E. Owens III, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
16. E.T. Dams, P. Laverman, W.J. Oyen, G. Storm, G.L. Scherphof, and J.W. van Der Meer et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 2000 1071 1079 (Pubitemid 30136603)
17. P. Laverman, M.G. Carstens, O.C. Boerman, E.T. Dams, W.J. Oyen, and N. van Rooijen et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection J. Pharmacol. Exp. Ther. 298 2001 607 612 (Pubitemid 32673411)
18. T. Ishida, R. Maeda, M. Ichihara, Y. Mukai, Y. Motoki, and Y. Manabe et al. The accelerated clearance on repeated injection of pegylated liposomes in rats: laboratory and histopathological study Cell. Mol. Biol. Lett. 7 2002 286
19. A.S. Abu Lila, H. Kiwada, and T. Ishida The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage J. Control. Release 172 2013 38 47
20. Z. Cheng, A. Al Zaki, J.Z. Hui, V.R. Muzykantov, and A. Tsourkas Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities Science 338 2012 903 910
21. V.R. Muzykantov Drug delivery by red blood cells: vascular carriers designed by mother nature Expert Opin. Drug Deliv. 7 2010 403 427
22. F. Pierige, S. Serafini, L. Rossi, and M. Magnani Cell-based drug delivery Adv. Drug Deliv. Rev. 60 2008 286 295 (Pubitemid 350236405)
23. M. Hamidi, and H. Tajerzadeh Carrier erythrocytes: an overview Drug Deliv. 10 2003 9 20 (Pubitemid 36205992)
24. P.H. Hinderling Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics Pharmacol. Rev. 49 1997 279 295 (Pubitemid 27414916)
25. L. Rossi, S. Serafini, L. Cenerini, F. Picardi, L. Bigi, and I. Panzani et al. Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease Biotechnol. Appl. Biochem. 33 2001 85 89 (Pubitemid 32304285)
26. S. Kontos, I.C. Kourtis, K.Y. Dane, and J.A. Hubbell Engineering antigens for in situ erythrocyte binding induces T-cell deletion Proc. Natl. Acad. Sci. U. S. A. 110 2013 E60 E68
27. L. Chiarantini, R. Argnani, S. Zucchini, L. Stevanato, P. Zabardi, and M.P. Grossi et al. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice Vaccine 15 1997 276 280 (Pubitemid 27118570)
28. E. Chambers, and S. Mitragotri Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes J. Control. Release 100 2004 111 119 (Pubitemid 39451782)
29. E. Chambers, and S. Mitragotri Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation Exp. Biol. Med. 232 2007 958 966 (Pubitemid 47026803)
30. A.C. Anselmo, V. Gupta, B.J. Zern, D. Pan, M. Zakrewsky, and V. Muzykantov et al. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells ACS Nano 7 2013 11129 11137
31. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat. Rev. Immunol. 5 2005 953 964 (Pubitemid 41746764)
32. B.A. Imhof, and M. Aurrand-Lions Adhesion mechanisms regulating the migration of monocytes Nat. Rev. Immunol. 4 2004 432 444 (Pubitemid 38745555)
33. C. Shi, and E.G. Pamer Monocyte recruitment during infection and inflammation Nat. Rev. Immunol. 11 2011 762 774
34. C. Murdoch, A. Giannoudis, and C.E. Lewis Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues Blood 104 2004 2224 2234 (Pubitemid 39331817)
35. E.V. Batrakova, H.E. Gendelman, and A.V. Kabanov Cell-mediated drug delivery Expert Opin. Drug Deliv. 8 2011 415 433
36. M. Barry, and R.C. Bleackley Cytotoxic T lymphocytes: all roads lead to death Nat. Rev. Immunol. 2 2002 401 409 (Pubitemid 37328747)
37. T.R. Mosmann, and R.L. Coffman TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annu. Rev. Immunol. 7 1989 145 173 (Pubitemid 19138011)
38. F. Sallusto, J. Geginat, and A. Lanzavecchia Central memory and effector memory T cell subsets: function, generation, and maintenance Annu. Rev. Immunol. 22 2004 745 763 (Pubitemid 38680440)
39. T.W. LeBien, and T.F. Tedder B lymphocytes: how they develop and function Blood 112 2008 1570 1580
40. N.P. Restifo, M.E. Dudley, and S.A. Rosenberg Adoptive immunotherapy for cancer: harnessing the T cell response Nat. Rev. Immunol. 12 2012 269 281
41. M.E. Dudley, and S.A. Rosenberg Adoptive-cell-transfer therapy for the treatment of patients with cancer Nat. Rev. Cancer 3 2003 666 675 (Pubitemid 37328821)
42. S.P. Kerkar, L. Sanchez-Perez, S. Yang, Z.A. Borman, P. Muranski, and Y. Ji et al. Genetic engineering of murine CD8 + and CD4 + T cells for preclinical adoptive immunotherapy studies J. Immunother. 34 2011 343 352
43. R.A. Morgan, M.E. Dudley, J.R. Wunderlich, M.S. Hughes, J.C. Yang, and R.M. Sherry et al. Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 2006 126 129 (Pubitemid 44547756)
44. M. Viguier, F. Lemaitre, O. Verola, M.S. Cho, G. Gorochov, and L. Dubertret et al. Foxp3 expressing CD4 + CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J. Immunol. 173 2004 1444 1453 (Pubitemid 38924326)
45. P.J. Tacken, I.J. de Vries, R. Torensma, and C.G. Figdor Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting Nat. Rev. Immunol. 7 2007 790 802 (Pubitemid 47480309)
46. J.M. Timmerman, and R. Levy Dendritic cell vaccines for cancer immunotherapy Annu. Rev. Med. 50 1999 507 529 (Pubitemid 29117080)
47. R.W. Childs, and M. Berg Bringing natural killer cells to the clinic: ex vivo manipulation Hematol. Am. Soc. Hematol. Educ. Program. 2013 2013 234 246
48. Z.M. Ruggeri Mechanisms initiating platelet thrombus formation Thromb. Haemost. 78 1997 611 616 (Pubitemid 27289313)
49. T.E. Foster, B.L. Puskas, B.R. Mandelbaum, M.B. Gerhardt, and S.A. Rodeo Platelet-rich plasma: from basic science to clinical applications Am. J. Sports Med. 37 2009 2259 2272
50. M.T. Stephan, and D.J. Irvine Enhancing cell therapies from the outside in: cell surface engineering using synthetic nanomaterials Nano Today 6 2011 309 325
51. L. Weiss, and R. Zeigel Cell surface negativity and the binding of positively charged particles J. Cell. Physiol. 77 1971 179 186
52. T. Xia, M. Kovochich, J. Brant, M. Hotze, J. Sempf, and T. Oberley et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm Nano Lett. 6 2006 1794 1807 (Pubitemid 44327550)
53. T. Xia, M. Kovochich, M. Liong, J.I. Zink, and A.E. Nel Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways ACS Nano 2 2008 85 96 (Pubitemid 351595956)
54. J.-Y. Yoon, H.-Y. Park, J.-H. Kim, and W.-S. Kim Adsorption of BSA on highly carboxylated microspheres - quantitative effects of surface functional groups and interaction forces J. Colloid Interface Sci. 177 1996 613 620
55. J.-Y. Yoon, J.-H. Kim, and W.-S. Kim Interpretation of protein adsorption phenomena onto functional microspheres Colloids Surf. B: Biointerfaces 12 1998 15 22 (Pubitemid 28561565)
56. A.J. Swiston, C. Cheng, S.H. Um, D.J. Irvine, R.E. Cohen, and M.F. Rubner Surface functionalization of living cells with multilayer patches Nano Lett. 8 2008 4446 4453
57. A.J. Swiston, J.B. Gilbert, D.J. Irvine, R.E. Cohen, and M.F. Rubner Freely suspended cellular "backpacks" lead to cell aggregate self-assembly Biomacromolecules 11 2010 1826 1832
58. F.C. Vasconcellos, A.J. Swiston, M.M. Beppu, R.E. Cohen, and M.F. Rubner Bioactive polyelectrolyte multilayers: hyaluronic acid mediated B lymphocyte adhesion Biomacromolecules 11 2010 2407 2414
59. N. Doshi, A.J. Swiston, J.B. Gilbert, M.L. Alcaraz, R.E. Cohen, and M.F. Rubner et al. Cell-based drug delivery devices using phagocytosis-resistant backpacks Adv. Mater. 23 2011 H105 H109
60. M.T. Stephan, J.J. Moon, S.H. Um, A. Bershteyn, and D.J. Irvine Therapeutic cell engineering with surface-conjugated synthetic nanoparticles Nat. Med. 16 2010 1035 1041
61. M.R. Choi, K.J. Stanton-Maxey, J.K. Stanley, C.S. Levin, R. Bardhan, and D. Akin et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors Nano Lett. 7 2007 3759 3765
62. E.V. Batrakova, S. Li, A.D. Reynolds, R.L. Mosley, T.K. Bronich, and A.V. Kabanov et al. A macrophage-nanozyme delivery system for Parkinson's disease Bioconjug. Chem. 18 2007 1498 1506 (Pubitemid 47464057)
63. A.M. Brynskikh, Y. Zhao, R.L. Mosley, S. Li, M.D. Boska, and N.L. Klyachko et al. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease Nanomedicine 5 2010 379 396
64. Y. Zhao, M.J. Haney, V. Mahajan, B.C. Reiner, A. Dunaevsky, and R.L. Mosley et al. Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson's disease J. Nanomedicine Nanotechnol. S4 2011
65. M.T. Stephan, S.B. Stephan, P. Bak, J. Chen, and D.J. Irvine Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles Biomaterials 33 2012 5776 5787
66. H. Dou, C.B. Grotepas, J.M. McMillan, C.J. Destache, M. Chaubal, and J. Werling et al. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS J. Immunol. 183 2009 661 669
67. M.R. Choi, R. Bardhan, K.J. Stanton-Maxey, S. Badve, H. Nakshatri, and K.M. Stantz et al. Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse Cancer Nanotechnol. 3 2012 47 54
68. J. Choi, H.Y. Kim, E.J. Ju, J. Jung, J. Park, and H.K. Chung et al. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors Biomaterials 33 2012 4195 4203
69. J.C. Murciano, S. Medinilla, D. Eslin, E. Atochina, D.B. Cines, and V.R. Muzykantov Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes Nat. Biotechnol. 21 2003 891 896 (Pubitemid 36936194)
70. M. Magnani, A. Fazi, F. Mangani, L. Rossi, and U. Mancini Methanol detoxification by enzyme-loaded erythrocytes Biotechnol. Appl. Biochem. 18 Pt 3 1993 217 226 (Pubitemid 2022755)
71. A. Fraternale, A. Casabianca, C. Orlandi, A. Cerasi, L. Chiarantini, and G. Brandi et al. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model Antiviral Res. 56 2002 263 272 (Pubitemid 35284299)
72. L. Rossi, S. Serafini, A. Antonelli, F. Pierige, A. Carnevali, and V. Battistelli et al. Macrophage depletion induced by clodronate-loaded erythrocytes J. Drug Target. 13 2005 99 111 (Pubitemid 40542542)
73. R.B. Moyes, H. Kirch, and J.R. DeLoach Enhanced biological activity of human recombinant interleukin 2 coupled to mouse red blood cells as evaluated using the mouse Meth A sarcoma model Biotechnol. Appl. Biochem. 23 Pt 1 1996 29 36 (Pubitemid 26057746)
74. F.J. Hsu, C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, and B. Taidi et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat. Med. 2 1996 52 58 (Pubitemid 26028073)
75. J. Wierecky, M.R. Muller, S. Wirths, E. Halder-Oehler, D. Dorfel, and S.M. Schmidt et al. Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients Cancer Res. 66 2006 5910 5918 (Pubitemid 43927146)
76. J.I. Mayordomo, T. Zorina, W.J. Storkus, L. Zitvogel, C. Celluzzi, and L.D. Falo et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nat. Med. 1 1995 1297 1302
77. C. Cole, J. Qiao, T. Kottke, R.M. Diaz, A. Ahmed, and L. Sanchez-Perez et al. Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells Nat. Med. 11 2005 1073 1081 (Pubitemid 41486829)
78. S.A. Rosenberg, N.P. Restifo, J.C. Yang, R.A. Morgan, and M.E. Dudley Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nat. Rev. Cancer 8 2008 299 308 (Pubitemid 351430867)
79. C.H. June Adoptive T, cell therapy for cancer in the clinic J. Clin. Invest. 117 2007 1466 1476 (Pubitemid 46871329)
80. M. Cheng, Y. Chen, W. Xiao, R. Sun, and Z. Tian NK cell-based immunotherapy for malignant diseases Cell. Mol. Immunol. 10 2013 230 252
81. M.M. Murray, K.P. Spindler, E. Abreu, J.A. Muller, A. Nedder, and M. Kelly et al. Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament J. Orthop. Res. 25 2007 81 91. (Pubitemid 46070734)